Overview

A Bioequivalence Study, Comparing Two Formulations of Ivermectin Lotion, 0.5%

Status:
Completed
Trial end date:
2017-08-18
Target enrollment:
Participant gender:
Summary
A Multi-Center, Double-Blind, Randomized, Placebo controlled, Parallel-group study, comparing Ivermectin Lotion, 0.5%
Phase:
Phase 1
Details
Lead Sponsor:
Taro Pharmaceuticals USA
Treatments:
Ivermectin